These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22205060)

  • 41. Metabolic syndrome: definition and therapeutic implications.
    Prasad H; Ryan DA; Celzo MF; Stapleton D
    Postgrad Med; 2012 Jan; 124(1):21-30. PubMed ID: 22314111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Metabolically obese with normal weight individuals: an intriguing phenotype].
    Beck E; Scheen AJ
    Rev Med Liege; 2009 Jan; 64(1):16-24. PubMed ID: 19317097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Obesity, metabolic syndrome and diabetes: cardiovascular implications and therapy].
    Alegría Ezquerra E; Castellano Vázquez JM; Alegría Barrero A
    Rev Esp Cardiol; 2008 Jul; 61(7):752-64. PubMed ID: 18590648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The metabolic syndrome.
    Balkau B; Eschwège E
    Lancet; 2005 Dec; 366(9501):1921; author reply 1923-4. PubMed ID: 16325688
    [No Abstract]   [Full Text] [Related]  

  • 45. [Physical Therapy for Metabolic Syndrome Prevention in Workers: Novel Role of Physical Therapist].
    Satoh T; Nemoto Y; Utumi T; Munakata M
    Nihon Eiseigaku Zasshi; 2016; 71(2):119-25. PubMed ID: 27246150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diabetes mellitus and cardiovascular diseases].
    Xiao XH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):678-9. PubMed ID: 17879524
    [No Abstract]   [Full Text] [Related]  

  • 47. [Metabolic syndrome and cardiovascular risk].
    Charbonnel B
    Rev Prat; 2005 Oct; 55(16):1765-71. PubMed ID: 16363426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease?
    Deedwania PC
    Circulation; 2004 Jan; 109(1):2-4. PubMed ID: 14707015
    [No Abstract]   [Full Text] [Related]  

  • 49. The metabolic syndrome: definition, pathogenesis and therapy.
    Demacker PN
    Eur J Clin Invest; 2007 Feb; 37(2):85-9. PubMed ID: 17217372
    [No Abstract]   [Full Text] [Related]  

  • 50. Obesity and the insulin resistance syndrome.
    Dunger DB
    Arch Dis Child; 2005 Jan; 90(1):1. PubMed ID: 15613499
    [No Abstract]   [Full Text] [Related]  

  • 51. [Metabolic syndrome: Diagnosis and management. An update].
    Názara Otero CA; Pose Reino A; Pena González E
    Clin Investig Arterioscler; 2016; 28(5):230-231. PubMed ID: 27296807
    [No Abstract]   [Full Text] [Related]  

  • 52. [The metabolic syndrome does not exist].
    Seidell JC
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):812. PubMed ID: 17469320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular risks in obesity.
    Uchegbu EC; Kopelman PG
    J Endocrinol Invest; 2002 Nov; 25(10):915-8. PubMed ID: 12508955
    [No Abstract]   [Full Text] [Related]  

  • 54. Association of metabolic syndrome in nondiabetic patients with increased risk for chronic kidney disease: the fat lady sings.
    Sedor JR; Schelling JR
    J Am Soc Nephrol; 2005 Jul; 16(7):1880-2. PubMed ID: 15944333
    [No Abstract]   [Full Text] [Related]  

  • 55. Metabolic syndrome as a marker of risk in type 2 diabetes.
    Gupta R
    Indian J Med Res; 2009 May; 129(5):481-4. PubMed ID: 19675374
    [No Abstract]   [Full Text] [Related]  

  • 56. Neglected cardiovascular risk factors.
    Lüscher TF
    Eur Heart J; 2015 Oct; 36(39):2621-3. PubMed ID: 26468255
    [No Abstract]   [Full Text] [Related]  

  • 57. The metabolic syndrome and the heart--a considered opinion.
    Leichman JG; Lavis VR; Aguilar D; Wilson CR; Taegtmeyer H
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i134-41. PubMed ID: 16598541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein H: its relevance to cardiovascular disease.
    Crook MA
    Atherosclerosis; 2010 Mar; 209(1):32-4. PubMed ID: 20045109
    [No Abstract]   [Full Text] [Related]  

  • 59. Impact of objectively-measured sleep duration on cardiometabolic health: A systematic review of recent evidence.
    Dejenie TA; G/Medhin MT; Admasu FT; Adella GA; Enyew EF; Kifle ZD; Seid MA; Mengstie MA; Abebe EC
    Front Endocrinol (Lausanne); 2022; 13():1064969. PubMed ID: 36601010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Editorial comment.
    Cohen MS
    Urology; 2009 Sep; 74(3):564-5; author reply 565. PubMed ID: 19716908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.